EVIVE Biotechnology

Quick facts

Marketed products

• RYZNEUTA · Other
  Efbemalenograstim alfa-vuxw binds to specific cell surface receptors on hematopoietic cells, stimulating their proliferation, differentiation, and functional activation.
• GRAN® · Other

Phase 3 pipeline

• F-627 · Oncology
  F-627 is a long-acting granulocyte colony-stimulating factor (G-CSF) analog that stimulates neutrophil production and mobilization.

Phase 2 pipeline

• EC regimen

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• EVIVE Biotechnology portfolio CI brief
• EVIVE Biotechnology pipeline updates RSS